Eastland in African deal

WEST Perth-based medical device manufacturer, Eastland Medical Systems, has secured a contract, through its South African subsidiary, to produce anti-malaria medication for the African continent. The agreement was signed between Eastland’s 65 per cent-owned subsidiary Eastland Medical Systems South Africa (EMSSA) and Star Medical (Botswana), with manufacturing expected to commence in mid 2008 following regulatory approvals on the anti-malaria treatment and the establishment of manufacturing facilities. A clinical validation study of the treatment, conducted in Nigeria, found a 100 per cent effective success rate in all patients tested. Eastland Medical Systems chief executive officer Dermot Patterson said negotiations were currently under way to acquire a new manufacturing plant. The manufacturing agreement follows a distribution agreement signed between EMSSA and Star in December, which granted EMSSA the distribution rights for its anti-malaria treatment to the 47 countries within sub-Saharan Africa. Eastland also announced that it had terminated an agreement, established in August 2005, to purchase an 80 per cent equity in South African medical device manufacturer, Elite Surgical Supplies, following the new agreement.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 31/10/18

1 year TSR5 year TSR
thWide Open Agriculture0%0%
240thRBR Group14%-3%
735thSUDA Pharmaceuticals-59%-27%
761stSky and Space Global-64%45%
744 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$42k Sold
$24k Issued
$61k Issued
Total value as at the date of the transaction
Source: Morningstar


174th-Wide Open Agriculture$552k
175th↑Sky and Space Global$503k
176th↓SUDA Pharmaceuticals$488k
177th-RBR Group$487k
178th↓JV Global$487k
239 listed industrial companies ranked by revenue.
Source: Morningstar

BNiQ Disclaimer